Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment
JAMA Internal Medicine · 01.03.2023 · 183 (3) · 203
DOI: 10.1001/jamainternmed.2022.6409 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.03.2023. Verfasst von Luke P Dawson und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Troponin, Myocardial Infarction. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Importance Prehospital point-of-care troponin testing and paramedic risk stratification might improve the efficiency of chest pain care pathways compared with existing processes with equivalent health outcomes, but the association with health care costs is unclear.
Objective
To analyze whether prehospital point-of-care troponin testing and paramedic risk stratification could result in cost savings compared with existing chest pain care pathways. Design, Setting, and Participants In this economic evaluation of adults with acute chest pain without ST-segment elevation, cost-minimization analysis was used to assess linked ambulance, emergency, and hospital attendance in the state of Victoria, Australia, between January 1, 2015, and June 30, 2019.
Interventions
Paramedic risk stratification and point-of-care troponin testing. Main Outcomes and Measures The outcome was estimated mean annualized statewide costs for acute chest pain. Between May 17 and June 25, 2022, decision tree models were developed to estimate costs under 3 pathways: (1) existing care, (2) paramedic risk stratification and point-of-care troponin testing without prehospital discharge, or (3) prehospital discharge and referral to a virtual emergency department (ED) for low-risk patients. Probabilities for the prehospital pathways were derived from a review of the literature. Multivariable probabilistic sensitivity analysis with 50 000 Monte Carlo iterations was used to estimate mean costs and cost differences among pathways.
Results
A total of 188 551 patients attended by ambulance for chest pain (mean [SD] age, 61.9 [18.3] years; 50.5% female; 49.5% male; Indigenous Australian, 2.0%) were included in the model. Estimated annualized infrastructure and staffing costs for the point-of-care troponin pathways, assuming a 5-year device life span, was $2.27 million for the pathway without prehospital discharge and $4.60 million for the pathway with prehospital discharge (incorporating virtual ED costs). In the decision tree model, total annual cost using prehospital point-of-care troponin and paramedic risk stratification was lower compared with existing care both without prehospital discharge (cost savings, $6.45 million; 95% uncertainty interval [UI], $0.59-$16.52 million; lower in 94.1% of iterations) and with prehospital discharge (cost savings, $42.84 million; 95% UI, $19.35-$72.26 million; lower in 100% of iterations). Conclusions and Relevance Prehospital point-of-care troponin and paramedic risk stratification for patients with acute chest pain could result in substantial cost savings. These findings should be considered by policy makers in decisions surrounding the potential utility of prehospital chest pain risk stratification and point-of-care troponin models provided that safety is confirmed in prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Cardiology, The Royal Melbourne Hospital, Victoria, Australia.
- Ambulance Victoria, Melbourne, Australia.
- Department of Paramedicine, Monash University, Melbourne, Victoria, Australia.
- The Baker Institute, Melbourne, Victoria, Australia.
Zitieren
APA
Dawson, L. P., Nehme, E., Nehme, Z., Zomer, E., Bloom, J., Cox, S., Anderson, D., Stephenson, M., Ball, J., Zhou, J., Lefkovits, J., Taylor, A. J., Horrigan, M., Chew, D. P., Kaye, D., Cullen, L., Mihalopoulos, C., Smith, K., & Stub, D. (2023). Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment. JAMA Internal Medicine, 183(3), 203. https://doi.org/10.1001/jamainternmed.2022.6409
Vancouver
Dawson LP, Nehme E, Nehme Z, Zomer E, Bloom J, Cox S, et al. Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment. JAMA Internal Medicine. 2023;183(3):203. doi:10.1001/jamainternmed.2022.6409
BibTeX
@article{Dawson2023,
author = {Dawson, Luke P and Nehme, Emily and Nehme, Ziad and Zomer, Ella and Bloom, Jason and Cox, Shelley and Anderson, David and Stephenson, Michael and Ball, Jocasta and Zhou, Jennifer and Lefkovits, Jeffrey and Taylor, Andrew J and Horrigan, Mark and Chew, Derek P and Kaye, David and Cullen, Louise and Mihalopoulos, Cathrine and Smith, Karen and Stub, Dion},
title = {Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment},
journal = {JAMA Internal Medicine},
year = {2023},
volume = {183},
number = {3},
pages = {203},
doi = {10.1001/jamainternmed.2022.6409}
}
EUVIMED